The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
-
* Corresponding author: Kenneth Rockwood Kenneth.Rockwood@Dal.ca
BMC Neurology 2007, 7:26 doi:10.1186/1471-2377-7-26
No comments have yet been made on this article.